BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31128292)

  • 1. 3D gastrointestinal models and organoids to study metabolism in human colon cancer.
    Silva-Almeida C; Ewart MA; Wilde C
    Semin Cell Dev Biol; 2020 Feb; 98():98-104. PubMed ID: 31128292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast tumour organoids: promising models for the genomic and functional characterisation of breast cancer.
    Roelofs C; Hollande F; Redvers R; Anderson RL; Merino D
    Biochem Soc Trans; 2019 Feb; 47(1):109-117. PubMed ID: 30626705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver-Tumor Hybrid Organoids for Modeling Tumor Growth and Drug Response In Vitro.
    Skardal A; Devarasetty M; Rodman C; Atala A; Soker S
    Ann Biomed Eng; 2015 Oct; 43(10):2361-73. PubMed ID: 25777294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor organoid models in precision medicine and investigating cancer-stromal interactions.
    Xu R; Zhou X; Wang S; Trinkle C
    Pharmacol Ther; 2021 Feb; 218():107668. PubMed ID: 32853629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut organoids: mini-tissues in culture to study intestinal physiology and disease.
    Almeqdadi M; Mana MD; Roper J; Yilmaz ÖH
    Am J Physiol Cell Physiol; 2019 Sep; 317(3):C405-C419. PubMed ID: 31216420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organoids: An intermediate modeling platform in precision oncology.
    Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
    Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.
    Tsai S; McOlash L; Palen K; Johnson B; Duris C; Yang Q; Dwinell MB; Hunt B; Evans DB; Gershan J; James MA
    BMC Cancer; 2018 Mar; 18(1):335. PubMed ID: 29587663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenograft and organoid model systems in cancer research.
    Bleijs M; van de Wetering M; Clevers H; Drost J
    EMBO J; 2019 Aug; 38(15):e101654. PubMed ID: 31282586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor organoids: synergistic applications, current challenges, and future prospects in cancer therapy.
    Qu J; Kalyani FS; Liu L; Cheng T; Chen L
    Cancer Commun (Lond); 2021 Dec; 41(12):1331-1353. PubMed ID: 34713636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use and application of 3D-organoid technology.
    Artegiani B; Clevers H
    Hum Mol Genet; 2018 Aug; 27(R2):R99-R107. PubMed ID: 29796608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organoid technology in cancer precision medicine.
    Xia X; Li F; He J; Aji R; Gao D
    Cancer Lett; 2019 Aug; 457():20-27. PubMed ID: 31078736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DNA methylation landscape of human cancer organoids available at the American type culture collection.
    Joshi R; Castro De Moura M; Piñeyro D; Alvarez-Errico D; Arribas C; Esteller M
    Epigenetics; 2020 Nov; 15(11):1167-1177. PubMed ID: 32396494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similarities and differences in metabolites of tongue cancer cells among two- and three-dimensional cultures and xenografts.
    Murakami S; Tanaka H; Nakayama T; Taniura N; Miyake T; Tani M; Kushima R; Yamamoto G; Sugihara H; Mukaisho KI
    Cancer Sci; 2021 Feb; 112(2):918-931. PubMed ID: 33244783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organoid models of gastrointestinal cancers in basic and translational research.
    Lau HCH; Kranenburg O; Xiao H; Yu J
    Nat Rev Gastroenterol Hepatol; 2020 Apr; 17(4):203-222. PubMed ID: 32099092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors.
    Cao W; Liu J; Wang L; Li M; Verstegen MMA; Yin Y; Ma B; Chen K; Bolkestein M; Sprengers D; van der Laan LJW; Doukas M; Kwekkeboom J; Smits R; Peppelenbosch MP; Pan Q
    Carcinogenesis; 2019 Mar; 40(1):145-154. PubMed ID: 30289434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organoid Models and Applications in Biomedical Research.
    Xinaris C; Brizi V; Remuzzi G
    Nephron; 2015; 130(3):191-9. PubMed ID: 26112599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bioassay to measure energy metabolism in mouse colonic crypts, organoids, and sorted stem cells.
    Fan YY; Davidson LA; Callaway ES; Wright GA; Safe S; Chapkin RS
    Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G1-9. PubMed ID: 25977509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease Modeling in Stem Cell-Derived 3D Organoid Systems.
    Dutta D; Heo I; Clevers H
    Trends Mol Med; 2017 May; 23(5):393-410. PubMed ID: 28341301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells.
    Ho BX; Pek NMQ; Soh BS
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29561796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.